A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03092323 |
|
Recruitment Status :
Recruiting
First Posted : March 27, 2017
Last Update Posted : May 15, 2023
|
Sponsor:
Sarcoma Alliance for Research through Collaboration
Collaborators:
Stand Up To Cancer
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Sarcoma Alliance for Research through Collaboration
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 1, 2025 |
| Estimated Study Completion Date : | September 1, 2028 |